K. Schelde

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’

Peter Junker, M. Østergaard, K. Stengaard-Pedersen, 2014, Arthritis Research & Therapy.

FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs.

K. D. Sørensen, Yonglun Luo, J. Cameron, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Cellular recycling‐driven in vivo half‐life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement

J. Cameron, K. Howard, F. Dagnæs-Hansen, 2018, Journal of controlled release : official journal of the Controlled Release Society.

A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation

J. Cameron, K. Bunting, K. Howard, 2019, Journal of Biological Chemistry.

A minimally invasive bronchoscopic approach for direct delivery to murine airways and application to models of pulmonary infection

C. Hodges, C. Flask, T. Kelley, 2023, Laboratory animals.